Calypso Names New CEO

Xconomy Seattle — 

Calypso Medical Technologies, the Seattle-based maker of a system to pinpoint radiation therapy for prostate cancer, said today that Ed Vertatschitsch has been named the company’s CEO. Vertatschitsch, who joined Calypso in 2003, has been at the helm on an interim basis since August, when former CEO Eric Meier left the company at a time of downsizing and reorganization of the company’s sales force. Vertatschitsch was previously the executive vice president of operations and R&D at Calypso before taking on the top job.